182 related articles for article (PubMed ID: 11035986)
21. The oncogenic properties of the HMG-I gene family.
Wood LJ; Maher JF; Bunton TE; Resar LM
Cancer Res; 2000 Aug; 60(15):4256-61. PubMed ID: 10945639
[TBL] [Abstract][Full Text] [Related]
22. Point mutations within AT-hook domains of the HMGI homologue HMGIYL1 affect binding to gene promoter but not to four-way junction DNA.
Schwanbeck R; Gerharz M; Drung A; Rogalla P; Piekielko A; Blank C; Bullerdiek J; Wiśniewski JR
Biochemistry; 2000 Nov; 39(47):14419-25. PubMed ID: 11087394
[TBL] [Abstract][Full Text] [Related]
23. High mobility group I/Y protein functions as a specific cofactor for Oct-2A: mapping of interaction domains.
Abdulkadir SA; Casolaro V; Tai AK; Thanos D; Ono SJ
J Leukoc Biol; 1998 Nov; 64(5):681-91. PubMed ID: 9823775
[TBL] [Abstract][Full Text] [Related]
24. The HMG-I(Y) A.T-hook peptide motif confers DNA-binding specificity to a structured chimeric protein.
Banks GC; Mohr B; Reeves R
J Biol Chem; 1999 Jun; 274(23):16536-44. PubMed ID: 10347218
[TBL] [Abstract][Full Text] [Related]
25. Pancreatic duct cell carcinomas express high levels of high mobility group I(Y) proteins.
Abe N; Watanabe T; Masaki T; Mori T; Sugiyama M; Uchimura H; Fujioka Y; Chiappetta G; Fusco A; Atomi Y
Cancer Res; 2000 Jun; 60(12):3117-22. PubMed ID: 10866296
[TBL] [Abstract][Full Text] [Related]
26. Chromosomal translocations in benign tumors: the HMGI proteins.
Hess JL
Am J Clin Pathol; 1998 Mar; 109(3):251-61. PubMed ID: 9495195
[TBL] [Abstract][Full Text] [Related]
27. Misexpression of disrupted HMGI architectural factors activates alternative pathways of tumorigenesis.
Tkachenko A; Ashar HR; Meloni AM; Sandberg AA; Chada KK
Cancer Res; 1997 Jun; 57(11):2276-80. PubMed ID: 9187132
[TBL] [Abstract][Full Text] [Related]
28. Distinct organization of DNA complexes of various HMGI/Y family proteins and their modulation upon mitotic phosphorylation.
Piekielko A; Drung A; Rogalla P; Schwanbeck R; Heyduk T; Gerharz M; Bullerdiek J; Wiśniewski JR
J Biol Chem; 2001 Jan; 276(3):1984-92. PubMed ID: 11034995
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional regulation of human insulin receptor gene by the high-mobility group protein HMGI(Y).
Brunetti A; Manfioletti G; Chiefari E; Goldfine ID; Foti D
FASEB J; 2001 Feb; 15(2):492-500. PubMed ID: 11156965
[TBL] [Abstract][Full Text] [Related]
30. Expression of HMGI-C and HMGI(Y) in ordinary lipoma and atypical lipomatous tumors: immunohistochemical reactivity correlates with karyotypic alterations.
Tallini G; Dal Cin P; Rhoden KJ; Chiapetta G; Manfioletti G; Giancotti V; Fusco A; Van den Berghe H; Sciot R
Am J Pathol; 1997 Jul; 151(1):37-43. PubMed ID: 9212729
[TBL] [Abstract][Full Text] [Related]
31. Structural and functional properties of linker histones and high mobility group proteins in polytene chromosomes.
Wiśniewski JR; Grossbach U
Int J Dev Biol; 1996 Feb; 40(1):177-87. PubMed ID: 8735927
[TBL] [Abstract][Full Text] [Related]
32. Misexpression of wild-type and truncated isoforms of the high-mobility group I proteins HMGI-C and HMGI(Y) in uterine leiomyomas.
Klotzbücher M; Wasserfall A; Fuhrmann U
Am J Pathol; 1999 Nov; 155(5):1535-42. PubMed ID: 10550310
[TBL] [Abstract][Full Text] [Related]
33. Organization, inducible-expression and chromosome localization of the human HMG-I(Y) nonhistone protein gene.
Friedmann M; Holth LT; Zoghbi HY; Reeves R
Nucleic Acids Res; 1993 Sep; 21(18):4259-67. PubMed ID: 8414980
[TBL] [Abstract][Full Text] [Related]
34. Expression of the HMGI(Y) gene products in human neuroblastic tumours correlates with differentiation status.
Giannini G; Kim CJ; Di Marcotullio L; Manfioletti G; Cardinali B; Cerignoli F; Ristori E; Zani M; Frati L; Screpanti I; Guilino A
Br J Cancer; 2000 Dec; 83(11):1503-9. PubMed ID: 11076660
[TBL] [Abstract][Full Text] [Related]
35. Protein footprinting reveals specific binding modes of a high mobility group protein I to DNAs of different conformation.
Frank O; Schwanbeck R; Wiśniewski JR
J Biol Chem; 1998 Aug; 273(32):20015-20. PubMed ID: 9685339
[TBL] [Abstract][Full Text] [Related]
36. Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains.
Ashar HR; Fejzo MS; Tkachenko A; Zhou X; Fletcher JA; Weremowicz S; Morton CC; Chada K
Cell; 1995 Jul; 82(1):57-65. PubMed ID: 7606786
[TBL] [Abstract][Full Text] [Related]
37. NF-kappaB mediated transcriptional activation is enhanced by the architectural factor HMGI-C.
Mantovani F; Covaceuszach S; Rustighi A; Sgarra R; Heath C; Goodwin GH; Manfioletti G
Nucleic Acids Res; 1998 Mar; 26(6):1433-9. PubMed ID: 9490789
[TBL] [Abstract][Full Text] [Related]
38. HMGI(Y) expression in human uterine leiomyomata. Involvement of another high-mobility group architectural factor in a benign neoplasm.
Williams AJ; Powell WL; Collins T; Morton CC
Am J Pathol; 1997 Mar; 150(3):911-8. PubMed ID: 9060829
[TBL] [Abstract][Full Text] [Related]
39. Specific binding of high-mobility-group I (HMGI) protein and histone H1 to the upstream AT-rich region of the murine beta interferon promoter: HMGI protein acts as a potential antirepressor of the promoter.
Bonnefoy E; Bandu MT; Doly J
Mol Cell Biol; 1999 Apr; 19(4):2803-16. PubMed ID: 10082546
[TBL] [Abstract][Full Text] [Related]
40. HMGI(Y) and Sp1 in addition to NF-kappa B regulate transcription of the MGSA/GRO alpha gene.
Wood LD; Farmer AA; Richmond A
Nucleic Acids Res; 1995 Oct; 23(20):4210-9. PubMed ID: 7479086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
